Evidence explainerPCOS & Cycle
Inositol for PCOS: What the Trials Show for Cycles, Weight and Fertility
Inositol may improve some metabolic measures in PCOS, but a review of 30 trials found little effect on other outcomes and called the evidence limited and inconclusive. The international guideline treats it as an option, not a fertility treatment.
Key takeaways
- A 2024 meta-analysis of 30 trials (2,230 women) found possible benefits of myo-inositol or D-chiro-inositol for some metabolic measures but likely no effect on other outcomes [1].
- Metformin may improve waist-hip ratio and excess hair more than inositol, while myo-inositol likely causes fewer stomach side effects [1].
- For fertility, a Cochrane review of 13 trials (1,472 women) rated the evidence low to very low quality and could not say whether inositol improves live births [3].
- The guideline says specific types, doses or combinations of inositol cannot be recommended [2].
What the trials found
The meta-analysis behind the 2023 guideline included 30 trials and pooled 19. It found benefits for myo-inositol or D-chiro-inositol on some metabolic measures and possible benefits of D-chiro-inositol for ovulation, but inositol may have no effect on other outcomes, and the authors called the evidence limited and inconclusive [1].
The guideline says inositol in any form could be considered based on individual preferences, noting limited harm and possible metabolic improvement but limited clinical benefit for ovulation, excess hair or weight [2].
Inositol vs metformin
Compared with inositol, metformin may improve waist-hip ratio and excess hair, with likely no difference for reproductive outcomes; myo-inositol likely causes fewer stomach side effects, though metformin's are usually mild and self-limited [1].
The guideline says metformin should be considered over inositol for excess hair and central weight [2]. Our pill vs metformin guide covers metformin in detail.
Inositol and fertility
A Cochrane review of 13 trials in 1,472 women with PCOS, mostly using myo-inositol before IVF, rated the evidence low to very low quality and was uncertain whether it improves live birth or clinical pregnancy rates [3].
The guideline says inositol, alone or combined with other treatments, should be considered experimental for fertility in PCOS [2].
Doses and product quality
The guideline says specific types, doses or combinations of inositol cannot currently be recommended, that its regulatory status and quality control differ from medicines, and that women taking it should tell their clinician [2].
In the US, inositol is a dietary supplement: the FDA does not approve supplements or test them before they are sold [4]. See our inositol monograph for more.
Quick answers
What dose of inositol should I take for PCOS?
The 2023 guideline says specific types, doses or combinations of inositol cannot currently be recommended because of a lack of quality evidence [2].
More in PCOS & Cycle
References
- [1]Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines. J Clin Endocrinol Metab, 2024.
- [2]Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab, 2023.
- [3]Inositol for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev, 2018.
- [4]Questions and Answers on Dietary Supplements. U.S. Food and Drug Administration, 2026.
